Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Seattle Genetics Deserves Its Stock Rally

July 17, 2019 0

Seattle Genetics Stock Rallied Seattle Genetics (SGEN) financial results started with Clay Siegall, Ph.D., President and …

Takeda: Advancing the Potential for Off-the-Shelf, Highly Scalable and Lower Cost CAR T-Cell Therapy for Cancer Treatment.

July 17, 2019 0

CiRA, Takeda & T-CiRA Less than five years ago the Center for iPS Cell Research and Application …

The Gilead and Galapagos Agreement Is a Big Win for Both Firms and Their Shareholders

July 15, 2019 0

Gilead and Galapagos Global Research Collaboration Gilead Sciences (GILD) and Galapagos NV (GLPG) entered into a 10-year global …

Exelixis: Encouraging Results from Cabozantinib Trial and a Good Decision by the Firm

July 15, 2019 0

Exelixis is Expanding Cohorts for COSMIC-021, the Phase 1b Trial for Cabozantinib From Exelixis (EXEL) we …

Are Illumina’s 2019 Challenges Transitory?

July 12, 2019 2

Illumina Stock Dropped Following Their Preliminary Revenue Announcement Illumina (ILMN) stock dropped 16% following the firm's announcement …

Regeneron’s Product Libtayo is Unique and Expected to Become a Best-Seller

July 9, 2019 0

The EC Granted Conditional Approval for Regeneron and Sanofi Product Libtayo for CSCC The European Commission (EC) …

Sangamo and Pfizer Announce Gene Therapy SB-525 Results in Hemophilia Patients and More

July 8, 2019 0

Sangamo and Pfizer Gene Therapy SB-525 Resulted in a Sustained Increase in Factor VIII Levels in …

Gilead to File NDA for Rheumatoid Arthritis Drug Filgotinib. Karyopharm Stock Gained 36% in Today’s Trading

July 3, 2019 0

Gilead to File NDA for Filgotinib for Rheumatoid Arthritis Meeting with the U.S. Food and Drug …

Small Biotech Firms That Can Become Top-Tier Giants

July 2, 2019 0

Small Biotech Firms That Can Become Top-Tier Biotech Giants We Start With... Abeona Therapeutics Abeona Therapeutics …

ImmunoGen: Experiencing Big Internal Changes

June 28, 2019 0

ImmunoGen’s Big Internal Changes ImmunoGen (IMGN) announced a radical impacting decision following the completion of an in-depth …

Atossa Genetics Has Promising News

June 27, 2019 0

Atossa Genetics Promising News for Endoxifen Atossa Genetics (ATOS) has promising news from a Phase 2 trial …

Searching for a New Promising Development-Stage Biotech Firm We Found and Picked This One

June 25, 2019 0

Krystal Biotech Krystal Biotech (KRYS) is a gene therapy firm focused on developing topical intradermal therapeutics for rare …

The FDA Approved AMAG Pharmaceuticals’ Product Vyleesi™ for Premenopausal Women with Acquired Generalized Hypoactive Sexual Desire Disorder

June 24, 2019 0

AMAG Pharmaceuticals’ Vyleesi™ was Approved The U.S. Food and Drug Administration (FDA) approved AMAG Pharmaceuticals’ (AMAG) product …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Seattle Genetics Deserves Its Stock Rally

Takeda: Advancing the Potential for Off-the-Shelf, Highly Scalable and Lower Cost CAR T-Cell Therapy for Cancer Treatment.

The Gilead and Galapagos Agreement Is a Big Win for Both Firms and Their Shareholders

Exelixis: Encouraging Results from Cabozantinib Trial and a Good Decision by the Firm

Are Illumina’s 2019 Challenges Transitory?

Regeneron’s Product Libtayo is Unique and Expected to Become a Best-Seller

Sangamo and Pfizer Announce Gene Therapy SB-525 Results in Hemophilia Patients and More

Gilead to File NDA for Rheumatoid Arthritis Drug Filgotinib. Karyopharm Stock Gained 36% in Today’s Trading

Small Biotech Firms That Can Become Top-Tier Giants

ImmunoGen: Experiencing Big Internal Changes

Atossa Genetics Has Promising News

Searching for a New Promising Development-Stage Biotech Firm We Found and Picked This One

The FDA Approved AMAG Pharmaceuticals’ Product Vyleesi™ for Premenopausal Women with Acquired Generalized Hypoactive Sexual Desire Disorder

Treating Hemoglobinopathies

News From Four Biotech Companies and Several Treatments

Pfizer to Acquire Array Biopharma at $48 a Share

bluebird bio: Why This Firm’s Stock Gained $6.37 Yesterday

Nektar Product NKTR-358 Shows Promise in Autoimmune and Chronic Inflammatory Conditions

Novartis: Psoriatic Arthritis Patients on Cosentyx Had No Radiologic Progression After 2 Years of Treatment

The ASCO 2019 Special Edition